Sort
21,281 grants matching “influenza”
Task X3: Evaluation of Clinical Samples from Influenza Clinical Trials
$1,054,656Carol Sabourin · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2020 · AI
5 YEAR STRATEGY FOR REDUCING MORBIDITY & MORTALITY CAUSED BY INFLUENZA
$1,052,476Caroline Brown · World Health Organization · U51 · FY2015 · IP
CENTER FOR COMPUTATIONAL MASS-SPECTROMETRY
$1,052,353Pavel A Pevzner · University Of California, San Diego · P41 · FY2011 · RR
Center for Computational Mass-Spectrometry
$1,052,353Pavel A Pevzner · University Of California, San Diego · P41 · FY2011 · RR
Clinical Trials of Vaccines for Respiratory Syncytial Virus and Related Viruses
$1,051,597Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Point-of-care Diagnosis and Surveillance of Known and Emerging Influenza Viruses
$1,051,183Timothy M Rose · Seattle Children'S Hospital · R01 · FY2016 · AI
FROM GENOMIC SEQUENCES TO PROTEIN STRUCTURE/FUNCTION
$1,050,546University Of Md Biotechnology Institute · P01 · FY2000 · GM
NIAID Centers of Excellence for Influenza Research and Response
$1,050,504Walter Orenstein · Emory University · N01 · FY2021 · AI
Adjuvant Discovery for Vaccines against West Nile Virus and Influenza
$1,050,000Dennis Carson · University Of California, San Diego · N01 · FY2015 · AI
SURVEILLANCE & RESPONSE TO SEASONAL & PANDEMIC INFLUENZA IN REGION OF THE AMERICA
$1,050,000Marcos Espinal · Pan American Health Organization · U51 · FY2013 · IP
RESPIRATORY PATHOGENS RESEARCH CENTERS (RPRC)
$1,049,995David Topham · University Of Rochester · N01 · FY2015 · AI
Fine Mechanisms of Adaptive NK Cell Formation Against HIV and SIV
$1,049,013Roger Keith Reeves · Duke University · R01 · FY2022 · AI
Universal room temperature stable influenza nanovaccine
$1,047,614Balaji Narasimhan · Iowa State University · R01 · FY2021 · AI
Systems biological analyses of innate responses to vaccination
$1,047,536Bali Pulendran · Emory University · U19 · FY2013 · AI
Conducting Public Health Research in China
$1,046,976Feng Zijian · Chinese Ctr-Disease Control/Prevention · U01 · FY2017 · GH
Assay Work for Malaria Vaccines - VTEU
$1,046,584Emmanuel B Walter · Duke University · N01 · FY2020 · AI
Identification and characterization of novel drugs that target the Influenza
$1,044,668Richard J. Whitley · University Of Alabama At Birmingham · U19 · FY2017 · AI
Multiplex diagnostic for biothreat C. psittaci & non-threat respiratory pathogens
$1,044,525Deborah Anne Dean · Children'S Hospital & Res Ctr At Oakland · R01 · FY2016 · AI
Vervet Research Colony as a Biomedical Resource
$1,044,153Matthew Jorgensen · Wake Forest University Health Sciences · P40 · FY2025 · OD
Center for Computational Mass-Spectrometry
$1,043,349Pavel A Pevzner · University Of California, San Diego · P41 · FY2012 · GM
Development of a Broad-Spectrum Inhibitor against Seasonal and Highly-Pathogenic Influenza Viruses
$1,041,945Richard K. Plemper · Georgia State University · R01 · FY2020 · AI
Omics-Based Predictive Modeling of Age-Dependent Outcome to Influenza Infection
$1,039,961Elodie Ghedin · New York University · U01 · FY2013 · AI
Pandemic Influenza Translational Research and Novel Drug Therapy
$1,039,364Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Computational Modeling Core
$1,037,741Katrina M. Waters · University Of Wisconsin-Madison · U19 · FY2017 · AI
Development of IFN-lambda3 for the Prevention and Treatment of Virus Infection
$1,036,895Sergei V Kotenko · Rbhs-New Jersey Medical School · R01 · FY2013 · AI